Pharmafile Logo
Pharmafocus logo
Advanced Search

Succinct Communications makes three appointments

December 9, 2011
Business Services, Medical Communications, Sales and Marketing Succinct

Succinct Communications has appointment a number of new staff members to support the growth of its organisation. Chris Stevenson joins …

Appointment

Dechra Pharmaceuticals PLC FDA Approval for manufacturing at Dales Pharmaceuticals

December 9, 2011
Manufacturing and Production, Research and Development FDA Approval

Dechra® Pharmaceuticals PLCFDA APPROVAL FOR MANUFACTURING AT DALES® PHARMACEUTICALS  Dales Pharmaceuticals (‘Dales’ or the ‘Company’), based in Skipton, North Yorkshire, UK, …

News
Press release

Erectile dysfunction drugs restricted on NHS

December 9, 2011
Sales and Marketing Cialis, ED, Levitra, NHS, PCTs, viagra

Health authorities in England are restricting the use of erectile dysfunction drugs to help cut costs. Pfizer’s Viagra, Lilly’s Cialis …

News
Novartis' facility in North Carolina

Novartis warned over standards at generics sites

December 9, 2011
Manufacturing and Production CGMP Failures, FDA compliance, Novartis, Sandoz

The FDA has warned Novartis that three North American production facilities operated by its generics subsidiary Sandoz are failing to …

News

Dr Rajeev Venkayya to head Takeda’s new vaccine business

December 9, 2011
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Takeda

Takeda will establish a new vaccine business division in January next year and will appoint Dr Rajeev Venkayya as its …

Appointment
Roche picture

Roche’s new breast cancer drug succeeds in late-stage trial

December 9, 2011
Research and Development, Sales and Marketing Roche, breast cancer, pertuzumab

Roche’s next generation breast cancer drug pertuzumab has helped patients to live over six months longer. CLEOPATRA, the first randomised …

News
daxas_web

NICE rejects Merck’s COPD drug Daxas

December 9, 2011
Sales and Marketing COPD, Daxas, Merck, Nycomed

NICE has not recommended Merck’s COPD drug Daxas and is asking for a new clinical trial to test its effectiveness. …

News
Mike Farrar

NHS to collaborate with pharma on innovation

December 8, 2011
Sales and Marketing ABPI, NHS, NHS Confederation, collaboration

 The NHS Confederation is to hold a series of strategic meetings with the pharma industry and the medical technology industries …

News
facebookweb

Europeans keen on medicines info – but not via Facebook or Twitter

December 8, 2011
Medical Communications Digital Blog, Facebook

 A new survey finds demand for information on medicines is strong in Europe, but consumers aren’t using social sites such …

News
AstraZeneca's global headquarters in London

AstraZeneca to cut 1,150 staff in the US

December 8, 2011
Research and Development, Sales and Marketing AstraZeneca, cuts

AstraZeneca will cut around 1,150 positions in the US as large patent expiries loom. The cuts will come primarily from …

News

Deepak Khanna becomes new ABPI president-elect

December 8, 2011
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Deepak Khanna

Deepak Khanna, senior vice president and UK managing director of Merck, Sharp and Dohme has been named as president-elect of …

Appointment
Merck picture

Merck establishes new R&D centre in China

December 8, 2011
Research and Development, Sales and Marketing

Merck is moving further into China by establishing its new Asian research and development headquarters in Beijing.  The Wangjing Park …

News

Biogen and Samsung invest $300m on joint biosimilars venture

December 8, 2011
Manufacturing and Production Biogen, Samsung, biosimilars

Biogen Idec and Samsung will invest $300 million in a joint venture to develop biosimilars. Both firms will contribute a …

News

Novo confident on ultra-long acting insulin

December 8, 2011
Sales and Marketing Novo Nordisk, diabetes, insulin

Novo Nordisk says a new combination of a long-acting insulin with a short-acting insulin helps patients maintain better control of …

News

New EU Cosmetics Regulation

December 7, 2011
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

The European Cosmetics Directive has been recast and the new legislation takes the form of Regulation 1223/2009.  As a Regulation, …

News
Press release
Lonza picture

Lonza to make Elan’s Alzheimer’s candidate

December 7, 2011
Manufacturing and Production Abbott, Elan, Lonza

Elan has awarded a manufacturing contract to Lonza to supply the active pharmaceutical ingredient (API) for its small-molecule candidate Alzheimer’s …

News

Contract research news in brief

December 7, 2011
Manufacturing and Production Almac, GVK Biosciences and PreClinOmics/AIT, PPD, Quintiles

Our round-up of news from the contract research sector includes PPD’s sales to a private equity consortium, new clinical supply …

News

Catalent Announces plans to increase Biologic Development and Manufacturing Capabilities

December 7, 2011
Manufacturing and Production

SOMERSET, NJ, December 7, 2011 — Catalent Pharma Solutions, a leading provider of drug and biologic development services, delivery technologies …

News
Press release
web

Ketchum Pleon appoints Andrew Lamb as healthcare digital strategist

December 7, 2011
Business Services, Medical Communications, Sales and Marketing Ketchum Pleon

Ketchum Pleon’s London office has appointed Andrew Lamb as a digital strategist for healthcare. Lamb will use his digital expertise …

Appointment

Health Protection Agency welcomes the Approval of ERWINAZE™ Biologics License Application for Treatment of Acute Lymphoblastic Leukemia

December 7, 2011
Manufacturing and Production

Salisbury, UK – 18th November 2011 –the Health Protection Agency (HPA) today welcomed the news that the U.S. Food and …

News
Press release
The Gateway to Local Adoption Series

Latest content

Alto Neuroscience announces new patent for depression treatment

January 15, 2026

Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech

January 15, 2026

Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project

January 14, 2026

Biocartis announces breast cancer research collaboration with US Mayo Clinic

January 14, 2026

Blue Earth announces first UK patient received prostate cancer injection

January 13, 2026